Principal Technologies

Principal Technologies EBIT per Share

The EBIT per Share of Principal Technologies (PTEC.V) as of Nov 8, 2026 is -0.09 CAD. In the previous year, EBIT per Share was -0.04 CAD — a change of 111.18% (lower).

EBIT per Share

-0.09CAD

YoY

111.18%

Last updated:

EBIT per Share of Principal Technologies is 2025 -0.09 CAD. EBIT per Share of Principal Technologies was 2024 -0.04 CAD. It decreases by 111.18% lower compared to the previous year.

The Principal Technologies EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
-0.00 CAD
Jan 1, 2021
-0.03 CAD
Jan 1, 2022
-0.08 CAD
Jan 1, 2023
-0.04 CAD
Jan 1, 2024
-0.04 CAD
Jan 1, 2025
-0.09 CAD
The Principal Technologies EBIT per Share history
YEAREBIT per ShareYoY
-0.09CAD+111.18%
-0.04CAD-6.56%
-0.04CAD-41.68%
-0.08CAD+198.07%
-0.03CAD+843.18%
-0.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Principal Technologies Stock analysis

What does Principal Technologies do? Principal Technologies Inc. generates revenue through project management of international scale clinical studies for medical device technologies, primarily serving healthcare technology companies with global distribution potential. The firm builds a portfolio of investments in healthcare technology firms that possess intellectual property enhancing medical treatment quality, cost efficiency, patient pathway optimization, and point of care technologies. Its subsidiaries, Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH, support these operations within the healthcare technology segment. The company targets healthcare technology companies seeking to scale globally while leveraging intellectual property for medical innovation. The business model relies on managing clinical studies for medical device technologies across international markets, which requires specialized expertise in healthcare technology project management. Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH operate as key subsidiaries facilitating these services. The firm's focus on intellectual property-driven healthcare technology investments attracts companies aiming to improve medical treatment quality and cost efficiency through global distribution strategies. Principal Technologies Inc. operates exclusively in the healthcare technology segment, providing project management services for clinical studies related to medical device technologies. Its subsidiaries, Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH, enable the company to offer comprehensive solutions for healthcare technology firms. The firm's investment portfolio centers on companies with intellectual property that enhances medical treatment quality, cost efficiency, patient pathway optimization, and point of care technologies, targeting clients seeking global market expansion through innovative healthcare solutions. Principal Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Principal Technologies stock

EBIT per Share of Principal Technologies is -0.09 CAD in 2025.

EBIT per Share of Principal Technologies changed from -0.04 CAD to -0.09 CAD, representing a 111.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Principal Technologies since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Principal Technologies

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Principal Technologies